Table 3.
Effect of Metformin on Hospitalizations and Adverse Events (AE)
| Event | Metformin n=26 | Placebo n=25 | ||||
|---|---|---|---|---|---|---|
| Event No. | Crude Rate, % | Rate per patient-yr | Event No. | Crude rate, % | Rate per patient-yr | |
| Hospitalizations | 2 | 8 | 0.08 | 0 | 0 | 0 |
| Hypoglycemia | 1 | 4 | 0.04 | 1 | 4 | 0.04 |
| Nausea | 11 | 42 | 0.42 | 4 | 16 | 0.16 |
| Vomiting | 7 | 27 | 0.27 | 3 | 12 | 0,12 |
| Diarrhea | 16 | 62 | 0.62 | 7 | 28 | 0.28 |
| Acid reflux | 2 | 8 | 0.08 | 4 | 16 | 0.16 |
| Flatulence | 4 | 15 | 0.15 | 0 | 0 | 0 |
| Lightheadedness | 6 | 23 | 0.23 | 4 | 16 | 0.16 |
| Headaches | 3 | 12 | 0.12 | 4 | 16 | 0.16 |
| Constipation | 1 | 4 | 0.04 | 0 | 0 | 0 |
| Abdominal cramping/pain | 2 | 8 | 0.08 | 3 | 12 | 0.12 |
| Weakness | 5 | 19 | 0.19 | 0 | 0 | 0 |
| Viral illness | 5 | 19 | 0.19 | 7 | 28 | 0.28 |
| Urinary tract infections | 1 | 4 | 0.04 | 2 | 8 | 0.08 |
| Sinus infections | 5 | 19 | 0.19 | 2 | 8 | 0.08 |